Representatives of Arvato Customer Group countries met with system developer Arvato Systems GmbH in Vienna, Austria, on 25 and 26 March to plan further improvements in the National Medicines Verification System.
Requirement team has been established since 2023 with aim to streamline planning of new changes and releases of medicines verification system. Working group evaluates, analyses and designs requirements of functional and technical changes of verification system.
LZVO is represented within the working group by IT manager Rihards Plivčs.
Meetings run in open and constructive discussions. Tasks at hand included:
- review the mission and scope of the working group;
- review the previously defined deliverables;
- evaluate and specify change requests.
Pleased to report that 16 representatives from 7 member countries participated, and that all planned results were achieved in an effective collaborative process. Many thanks to the colleagues at AMVS (https://www.amvs-medicines.at/en/) for inviting us for this important gathering!